Cubist Systematic Strategies, LLC Arcutis Biotherapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.25 - $11.77 $281,004 - $1.02 Million	-86,463 Reduced 80.68%	20,705 $205,000
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $197,189 - $516,549	107,168 New	107,168 $346,000
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $1.16 Million - $1.69 Million	83,033 Added 8395.65%	84,022 $1.24 Million
Q3 2022 Nov 14, 2022	SELL	$17.85 - $26.95 $857,835 - $1.3 Million	-48,058 Reduced 97.98%	989 $19,000
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $693,665 - $943,011	42,478 Added 646.64%	49,047 $1.05 Million
Q1 2022 May 16, 2022	SELL	$14.38 - $22.79 $103,766 - $164,452	-7,216 Reduced 52.35%	6,569 $127,000
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $186,740 - $317,883	12,466 Added 945.11%	13,785 $286,000
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $25,121 - $35,311	-1,303 Reduced 49.69%	1,319 $32,000
Q2 2021 Aug 16, 2021	SELL	$24.42 - $34.75 $272,209 - $387,358	-11,147 Reduced 80.96%	2,622 $72,000
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $295,132 - $446,015	12,061 Added 706.15%	13,769 $398,000
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $5,363 - $9,550	301 Added 21.39%	1,708 $48,000
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $32,980 - $45,417	1,407 New	1,407 $41,000

193

127M

5.43M

257K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $563M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.